National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents-Reference-Cited by-同舟云学术

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

Published:2008-08 Issue:2 Volume:59 Page:209-217
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Doherty Sean D.,Van Voorhees Abby,Lebwohl Mark G.,Korman Neil J.,Young Melodie S.,Hsu Sylvia

Publisher

Elsevier BV

Subject

Dermatology

Reference52 articles.

1. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial;Chaudhari;Lancet,2001

2. A randomized trial of etanercept as monotherapy for psoriasis;Gottlieb;Arch Dermatol,2003

3. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION);Saurat;Br J Dermatol,2008

4. Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial;Menter;J Am Acad Dermatol,2008

5. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation;Antoni;Arthritis Rheum,2002

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy;Journal of Infection and Public Health;2024-06

2. Annual tuberculosis screening in patients on biologics has questionable value;Journal of the American Academy of Dermatology;2024-03

3. COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study;Frontiers in Immunology;2023-03-16

4. Chronic Spontaneous Urticaria on Omalizumab Therapy and Latent Tuberculosis Infection: A New Case Report;Journal of Cosmetics, Dermatological Sciences and Applications;2023

5. Anti-tumor Necrosis Factor-α Antagonists and Tuberculosis;Integrated Science;2023